On October 8, 2019 Seattle Genetics, Inc. (Nasdaq: SGEN) reported that it will report its third quarter 2019 financial results on Tuesday, October 29, 2019 after the close of financial markets (Press release, Seattle Genetics, OCT 8, 2019, View Source [SID1234540105]). Following the announcement, company management will host a conference call and webcast discussion of the results and provide a general corporate update. Access to the event can be obtained as follows:
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
LIVE access on Tuesday, October 29, 2019
1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time
Telephone 800-353-6461 (domestic) or +1 334-323-0501 (international); conference ID 9057897
Webcast with slides available at www.seattlegenetics.com in the Investors section
REPLAY access
Telephone replay will be available beginning at approximately 4:30 p.m. PT on Tuesday, October 29, 2019 through 5:00 p.m. PT on Friday, November 1, 2019 by calling 888-203-1112 (domestic) or +1 719-457-0820 (international); conference ID 9057897
Webcast replay will be available on the Seattle Genetics website at www.seattlegenetics.com in the Investors section